Researchers have developed a new method for finding appropriate treatme for young paties with cancer.
According to RCO News Agency, A Pan -Canadian group has devised a new way to quickly find personal treatmes for young paties with cancer. They achieved this new method by growing cancer tumors in the egg and analyzing their proteins.
The group, led by researchers at the University and Research Institute of Children’s Hospital, is the first group to combine these two methods in Canada to ideify and test the drug for a young patie at the time of treatme.
Their success in finding a new drug for the patie shows how the study of proteins called proteumics can be a valuable suppleme to the study of genomic (genomic) in cancer therapies.
Proteomix: Complemeary approach to ideify treatme
While genes carry protein -making instructions, proteins themselves are the functional units of our cells. Most drugs work by changing the activity of protein, so the researchers wondered whether proteomics could reveal the hidden weaknesses of the tumors that genetic tests alone may be incapable of discovering.
After the standard chemotherapy failed and the tumor was resista to the drug selected by genomics, the researchers turned to proteomix and found that the tumor metabolism relies heavily on an enzyme called SHMT۲.
The strategy of the researchers was to use sertraline, a common aidepressa, to inhibit SHMT2 and discoinue tumor access to a key energy source.
Tumor reproduction in eggs
The group used a method to test their idea, including the growth of a small piece of patie tumor on the egg that acts as a host for the tumor. The growth of an ideical tumor outside the patie’s body gave them a way to test the personalized drug response within a few weeks.
This method speeds up the evaluation process of a treatme option in such a way that it is not possible to traditional methods. It can be quickly confirmed whether the drug we have ideified through proteomix can really be effective for the patie’s tumor.
Encouraging results, but need to study further
The results were promising but not enough. After the beginning of the sertraline treatme, the tumor’s growth slowed, but it did not stop, which means that additional treatme is still needed.
While there is further study of conducting, this study shows that the researchers’ approach can provide personalized therapeutic recommendations at a speed to help paties with rare cancers.
The end of the message
(tagstotranslate) Egg (T) Cancer
